Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 838.00
+21.10 (2.58%)
Jul 10, 2026, 3:29 PM IST
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 164.6 billion as of July 10, 2026. Its market cap has decreased by -10.26% in one year.
Market Cap
164.60B
Enterprise Value
176.82B
Revenue
73.45B
Ranking
n/a
PE Ratio
24.39
Stock Price
838.00
Market Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 164.60B, an increase of 1,728.58%. That is a compound annual growth rate of 21.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 164.60B | -1.03% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 343.99B |
| Wockhardt | 294.22B |
| Piramal Pharma | 235.12B |
| Eris Lifesciences | 198.32B |
| NATCO Pharma | 176.26B |
| Cohance Lifesciences | 172.88B |
| Alivus Life Sciences | 142.39B |
| Akums Drugs and Pharmaceuticals | 107.47B |